🚀 Exciting news! Mission Bio announces the Tapestri Single-cell Multiple Myeloma Multiomics Solution! This breakthrough offers unmatched insights for MM research & drug development, transforming how we understand and treat the disease.
Learn more here 👉 https://t.co/Grpy9F7m44
Last call for savings! 📢
Mission Bio is offering limited-time discounts on Tapestri® kits and warranties to help academic and non-profit labs stretch their budgets further — and still generate high-impact single-cell data.
Learn more 👉 https://t.co/f9jp82ateD
We're having a blast at #EHA25! 🇮🇹
Visit our team at Booth M.10 to learn more about our Single-Cell Genotype and Targeted Gene Expression assay—the industry’s first solution enabling simultaneous profiling of genotype and targeted gene expression in over 10,000 single cells
We're excited to announce our newest advancement in precision oncology: the Single-Cell Genotype and Targeted Gene Expression assay! This solution enables simultaneous profiling of genotype and targeted gene expression in over 10,000 cells 🎉
Learn more➡️ https://t.co/7E3ttKF0iO
💸 Budget tight? We’ve got your back.
Mission Bio is offering limited-time discounts on Tapestri® kits and warranties to help academic and non-profit labs stretch their budgets further — and still generate high-impact single-cell data.
Learn more 👉 https://t.co/f9jp82ateD
Published today in @Nature, researchers from @CRGenomica and @BellinzonaIrb utilized Tapestri to develop EPI-clone, which tracks clonal dynamics in hematopoiesis with naturally occurring DNA methylation patterns
Learn more here ➡️ https://t.co/UpiOVlEvoj
#ASGCT2025 is in full swing! We're having a blast in New Orleans meeting everyone and sharing how Tapestri is advancing genome editing validation with single-cell precision.
Swing by Booth #1749 to say hello to our team! 👋
At #ASGCT2025? Don’t miss our poster on advancing genome editing validation with single-cell precision
🧬 Comprehensive On- and Off-target Validation Using Integrated rhAmpSeq and Targeted DNA Resequencing Single-Cell Technology
📅 May 15 | 5:30 PM CT
https://t.co/WbLN3maSed
🎉 We're headed to the Big Easy! Join us next week in New Orleans for @ASGCTherapy#ASGCT2025 🎉
Visit Mission Bio at Booth #1749 to learn more about how Tapestri is advancing #cgt characterization 🧬
Check out the *can't-miss* presentations here ➡️ https://t.co/gnVSQeSuee
Join us TOMORROW, May 8 @ 12pm ET for an exciting webinar! ⤵️
🧬 Tech Overview: scDNA and multiomics sequencing with Tapestri
📕 Pub Spotlight: Risk of second tumors after CAR-T cell therapy
💸 Options for Access, including no CapEx required
Register➡️ https://t.co/8YeDjgsk7V
Our partnership with Integrated DNA Technologies (@idtdna) is built on the principle of therapeutic safety— bringing single-cell resolution and unmatched precision to genome editing analysis.
Read the full story👉https://t.co/jnSuKCDYAe
Bulk sequencing and traditional assays miss critical details that impact the safety and efficacy of cell therapies. 🧐
With the Tapestri, you can interrogate zygosity, detect off-target effects, and assess immunophenotype—all in one assay.
Learn more🔗https://t.co/lMfqR1Sc91
Our team is having an *AWSOM* time in Atlanta today at the 4th annual Atlanta Workshop of Single-cell Omics. If you're attending, be sure to swing by our table to say hi! 👋
Learn more about the Tapestri platform here ➡️ https://t.co/TrqPSviGtZ
Actionable Insights, Accelerated Outcomes 💪
Get the right drug to market faster with PAD services. Learn more about PAD services for drug development here ➡️ https://t.co/muW2SSf4Bc
Your partner at every step 🤝
From assay design to sample analysis and data interpretation, the PAD Services Team is here to help.
Learn more ➡️ https://t.co/3BhhG0th4b
🚨Last chance to register! In this live webinar, learn how researchers from @CincyChildrens utilized single-cell DNA + Fusion multi-omic analysis for acute leukemias
📅 Thursday, February 27
⏰11:30a ET | 8:30a PT
Register now to save your spot! ➡️ https://t.co/M5fKcZjDOr
[Live Webinar] Learn how researchers from @CincyChildrens utilized single-cell DNA + Fusion multi-omic analysis for acute leukemias
📅 Thursday, February 27
⏰ 11:30a ET | 8:30a PT
Register now to save your spot! ➡️ https://t.co/M5fKcZjDOr
📌One week away! Join us for a webinar Jan 30th where @wellhausrn of @PennMedicine will share groundbreaking insights into the potential of epitope editing to revolutionize immunotherapies for blood cancers and HIV reservoir elimination
Register here: https://t.co/3VMrQrwSio
📌 📅 Save the date! Join us Thursday, January 30 for a live webinar with Dr. Nils Wellhausen of @PennMedicine. He'll be discussing how epitope editing enables safe, CD45-directed CAR-T therapies for blood cancers.
Register here ➡️ https://t.co/mZPvsydXVG
Exciting news! Announced today, Mission Bio will be collaborating with @DrOlaLandgren & @SylvesterCancer team who will leverage the Tapestri Single-cell DNA Multiple Myeloma Panel to examine MM at an unprecedented level of clonal detail.
Learn more 👉 https://t.co/Ibpz2M2W9X
In anticipation of #ASH24 right around the corner, we'll be highlighting poster and oral presentations that utilize MB technology!
🗒️ 4333: Clinical Application of Single-Cell MRD By Genotype and Phenotype in AML
📅 12/9 | 6-8p
Get all the info here 👉https://t.co/aYYZCUFx3m